Loading...

Abbvie Inc (NYSE:ABBV)

152.12 USD +3.01 USD ( +2.02% )
Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist

Profitability Summary

74/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Revenue
Abbvie Inc
56.7B
Growth Rates
1 Year
13%
3 Years
20%
5 Years
17%
Operating Income
Abbvie Inc
20.1B
Growth Rates
1 Year
53%
3 Years
18%
5 Years
16%
Net Income
Abbvie Inc
12.5B
Growth Rates
1 Year
142%
3 Years
33%
5 Years
15%

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Gross Margin
Abbvie Inc
70%
Operating Margin
Abbvie Inc
35%
Net Margin
Abbvie Inc
22%

ABBV Earnings Waterfall
Abbvie Inc

Revenue
56.7B USD
Cost of Revenue
-17.1B USD
Gross Profit
39.6B USD
Operating Expenses
-19.4B USD
Operating Income
20.1B USD
Other Expenses
-7.7B USD
Net Income
12.5B USD

Margins Comparison
Abbvie Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Abbvie Inc
NYSE:ABBV
263B USD
70%
35%
22%
US
Amgen Inc
NASDAQ:AMGN
135B USD
75%
30%
22%
AU
CSL Ltd
ASX:CSL
131B AUD
55%
28%
22%
US
Gilead Sciences Inc
NASDAQ:GILD
80.7B USD
76%
36%
16%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
75.2B USD
85%
55%
48%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
68.6B USD
88%
38%
31%
Country US
Market Cap 263B USD
Gross Margin
70%
Operating Margin
35%
Net Margin
22%
Country US
Market Cap 135B USD
Gross Margin
75%
Operating Margin
30%
Net Margin
22%
Country AU
Market Cap 131B AUD
Gross Margin
55%
Operating Margin
28%
Net Margin
22%
Country US
Market Cap 80.7B USD
Gross Margin
76%
Operating Margin
36%
Net Margin
16%
Country US
Market Cap 75.2B USD
Gross Margin
85%
Operating Margin
55%
Net Margin
48%
Country US
Market Cap 68.6B USD
Gross Margin
88%
Operating Margin
38%
Net Margin
31%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

ROE
Abbvie Inc
83%
ROA
Abbvie Inc
9%
ROCE
Abbvie Inc
18%
ROIC
Abbvie Inc
13%

Return on Capital Comparison
Abbvie Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Abbvie Inc
NYSE:ABBV
263B USD
83%
9%
18%
13%
US
Amgen Inc
NASDAQ:AMGN
135B USD
112%
9%
17%
14%
AU
CSL Ltd
ASX:CSL
131B AUD
21%
11%
17%
17%
US
Gilead Sciences Inc
NASDAQ:GILD
80.7B USD
23%
7%
18%
13%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
75.2B USD
50%
36%
48%
49%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
68.6B USD
25%
19%
27%
44%
Country US
Market Cap 263B USD
ROE
83%
ROA
9%
ROCE
18%
ROIC
13%
Country US
Market Cap 135B USD
ROE
112%
ROA
9%
ROCE
17%
ROIC
14%
Country AU
Market Cap 131B AUD
ROE
21%
ROA
11%
ROCE
17%
ROIC
17%
Country US
Market Cap 80.7B USD
ROE
23%
ROA
7%
ROCE
18%
ROIC
13%
Country US
Market Cap 75.2B USD
ROE
50%
ROA
36%
ROCE
48%
ROIC
49%
Country US
Market Cap 68.6B USD
ROE
25%
ROA
19%
ROCE
27%
ROIC
44%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Operating Cash Flow
Abbvie Inc
22.8B
Growth Rates
1 Year
22%
3 Years
18%
5 Years
27%
Capital Expenditures
Abbvie Inc
1.1B
Growth Rates
1 Year
N/A
3 Years
N/A
5 Years
N/A
Free Cash Flow
Abbvie Inc
23.9B
Growth Rates
1 Year
35%
3 Years
22%
5 Years
30%

See Also

Other Stocks
Time Machine